M. Jiang

发表

In Vitro Phenotypic Characterization of Hepatitis C Virus NS3 Protease Variants Observed in Clinical Studies of Telaprevir

Tara L. Kieffer, B. G. Rao, O. Nicolas, 2013, Antimicrobial Agents and Chemotherapy.

MicroRNA‐155 controls Toll‐like receptor 3‐ and hepatitis C virus‐induced immune responses in the liver

G. Gerken, E. Zhang, X. Zhang, 2014, Journal of viral hepatitis.

Establishing a new animal model for hepadnaviral infection: susceptibility of Chinese Marmota-species to woodchuck hepatitis virus infection.

Z. Meng, M. Roggendorf, Hu Wang, 2011, The Journal of general virology.

Toll‐like receptor‐mediated immune responses are attenuated in the presence of high levels of hepatitis B virus surface antigen

G. Gerken, Mengji Lu, M. Trippler, 2014, Journal of viral hepatitis.

Hepatitis C Viral Evolution in Genotype 1 Treatment-Naïve and Treatment-Experienced Patients Receiving Telaprevir-Based Therapy in Clinical Trials

Tara L. Kieffer, A. Kwong, S. Zeuzem, 2012, PloS one.

Telaprevir‐based treatment effects on hepatitis C virus in liver and blood

A. Kwong, J. Sullivan, I. Jacobson, 2014, Hepatology.

Corticosteroids shift the Toll-like receptor response pattern of primary-isolated murine liver cells from an inflammatory to an anti-inflammatory state.

G. Gerken, J. Sowa, Mengji Lu, 2011, International immunology.

Toll‐like receptor‐induced innate immune responses in non‐parenchymal liver cells are cell type‐specific

G. Gerken, Z. Meng, Mengji Lu, 2010, Immunology.

Modulation of hepatitis B virus replication and hepatocyte differentiation by MicroRNA‐1

Zhiyong Ma, Mengji Lu, E. Zhang, 2011, Hepatology.

Genotypic and Phenotypic Analyses of Hepatitis C Virus Variants Observed in Clinical Studies of VX-222, a Nonnucleoside NS5B Polymerase Inhibitor

Tara L. Kieffer, B. G. Rao, O. Nicolas, 2014, Antimicrobial Agents and Chemotherapy.

Hepatitis B virus suppresses toll‐like receptor–mediated innate immune responses in murine parenchymal and nonparenchymal liver cells

Dongliang Yang, Mengji Lu, Rongjuan Pei, 2009, Hepatology.

1184 CHARACTERIZATION OF HCV VARIANTS IN GENOTYPE 1 TREATMENT-NAIVE PATIENTS ADMINISTERED THE COMBINATION OF TVR AND VX-222 IN DUAL ARMS OF ZENITH STUDY

A. Bisceglie, D. Bartels, M. Koziel, 2012 .

Immunostaining of PD-1/PD-Ls in liver tissues of patients with hepatitis and hepatocellular carcinoma.

Baoju Wang, M. Roggendorf, Jun-zhong Wang, 2011, World journal of gastroenterology.

Immunostaining of PD-1/PD-Ls in liver tissues of patients with hepatitis and hepatoellulararinoma hepatoellulararinoma

Baoju Wang, Mengji Lu, M. Roggendorf, 2011 .

Molecular characterization of woodchuck interleukin-10 receptor and enhanced function of specific T cells from chronically infected woodchucks following its blockade.

Jia Liu, Baoju Wang, Z. Meng, 2012, Comparative immunology, microbiology and infectious diseases.

TLR1/2 Ligand–Stimulated Mouse Liver Endothelial Cells Secrete IL-12 and Trigger CD8+ T Cell Immunity In Vitro

Jia Liu, Zhiyong Ma, Mengji Lu, 2013, The Journal of Immunology.

This information is current as T Cell Immunity In Vitro + CD 8 Endothelial Cells Secrete IL-12 and Trigger Stimulated Mouse Liver − TLR 1 / 2 Ligand

Jia Liu, Zhiyong Ma, Mengji Lu, 2013 .

Toxoplasma gondii: enzyme-linked immunosorbent assay based on a recombinant multi-epitope peptide for distinguishing recent from past infection in human sera.

R. Gong, Jin Si, M. Jiang, 2013, Experimental parasitology.

Evaluation of a Recombinant Multiepitope Peptide for Serodiagnosis of Toxoplasma gondii Infection

R. Gong, Jin Si, M. Jiang, 2012, Clinical and Vaccine Immunology.

The interferon stimulated gene 15 functions as a proviral factor for the hepatitis C virus and as a regulator of the IFN response

G. Gerken, Mengji Lu, S. Kottilil, 2010, Gut.

Inhibitory effect of biosynthetic nanoscale peptide Melittin on hepatocellular carcinoma, driven by survivin promoter.

R. Gong, G. Ji, Jin Si, 2014, Journal of biomedical nanotechnology.